StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
StockNews.com initiated coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Free Report) in a research note published on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Citigroup cut their price target on shares of Eiger BioPharmaceuticals from $4.00 to $3.00 and set a buy rating on the stock in […]
More Stories
Smart Companions or Digital Dangers? AI Plush Toys Spark Debate Among Parents
Curio, a startup based in Redwood City, California, founded by Misha Sallee and Sam Eaton, is experimenting with an innovative...
Citigroup Inc. Sells 9,476 Shares of United Community Banks, Inc. $UCB
Citigroup Inc. lowered its stake in United Community Banks, Inc. (NASDAQ:UCB – Free Report) by 4.0% in the 1st quarter,...
PNC Financial Services Group Inc. Purchases 249 Shares of Prosperity Bancshares, Inc. $PB
PNC Financial Services Group Inc. increased its position in Prosperity Bancshares, Inc. (NYSE:PB – Free Report) by 9.2% during the...
Prosperity Bancshares, Inc. $PB Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System lessened its stake in shares of Prosperity Bancshares, Inc. (NYSE:PB – Free Report) by...
Cetera Investment Advisers Has $483,000 Holdings in Highwoods Properties, Inc. $HIW
Cetera Investment Advisers raised its position in Highwoods Properties, Inc. (NYSE:HIW – Free Report) by 28.5% during the first quarter,...
PVH Corp. $PVH Shares Acquired by Cetera Investment Advisers
Cetera Investment Advisers grew its holdings in PVH Corp. (NYSE:PVH – Free Report) by 63.5% during the 1st quarter, according...